135 related articles for article (PubMed ID: 29508938)
1. Cultural adaptation and validation of the Chinese version of the expanded prostate cancer index composite.
Lee TK; Poon DMC; Ng ACF; Ho T; Singh-Carlson S; Joffres M; Oshan G; Kohli J; Kwan W
Asia Pac J Clin Oncol; 2018 Mar; 14 Suppl 1():10-15. PubMed ID: 29508938
[TBL] [Abstract][Full Text] [Related]
2. Cross-cultural adaptation and validation of the French version of the Expanded Prostate cancer Index Composite questionnaire for health-related quality of life in prostate cancer patients.
Anota A; Mariet AS; Maingon P; Joly F; Bosset JF; Guizard AV; Bittard H; Velten M; Mercier M
Health Qual Life Outcomes; 2016 Dec; 14(1):168. PubMed ID: 27923377
[TBL] [Abstract][Full Text] [Related]
3. The German version of the Expanded Prostate Cancer Index Composite (EPIC): translation, validation and minimal important difference estimation.
Umbehr MH; Bachmann LM; Poyet C; Hammerer P; Steurer J; Puhan MA; Frei A
Health Qual Life Outcomes; 2018 Feb; 16(1):36. PubMed ID: 29458434
[TBL] [Abstract][Full Text] [Related]
4. Validation of the Italian version of the abbreviated expanded prostate Cancer index composite (EPIC-26) in men with prostate Cancer.
Marzorati C; Monzani D; Mazzocco K; Masiero M; Pavan F; Monturano M; Pravettoni G
Health Qual Life Outcomes; 2019 Aug; 17(1):147. PubMed ID: 31464649
[TBL] [Abstract][Full Text] [Related]
5. Cultural adaptation and validation of the Korean version of the EORTC QLQ-CR29 in patients with colorectal cancer.
Ihn MH; Lee SM; Son IT; Park JT; Oh HK; Kim DW; Kang SB
Support Care Cancer; 2015 Dec; 23(12):3493-501. PubMed ID: 25824366
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument for measuring health-related quality of life among prostate cancer survivors.
Szymanski KM; Wei JT; Dunn RL; Sanda MG
Urology; 2010 Nov; 76(5):1245-50. PubMed ID: 20350762
[TBL] [Abstract][Full Text] [Related]
7. Validation study of a Chinese version of Partners in Health in Hong Kong (C-PIH HK).
Chiu TM; Tam KT; Siu CF; Chau PW; Battersby M
Qual Life Res; 2017 Jan; 26(1):199-203. PubMed ID: 27216940
[TBL] [Abstract][Full Text] [Related]
8. Validation of the Chinese version of the Head and Neck Patient Symptom Checklist for measuring nutrition impact symptoms during radiotherapy in patients with head and neck cancer.
Jin S; Lu Q; Pang D; Sun Y; Xiao S; Zheng B; Cui H
Support Care Cancer; 2019 Dec; 27(12):4705-4711. PubMed ID: 30949830
[TBL] [Abstract][Full Text] [Related]
9. Standardising the Assessment of Patient-reported Outcome Measures in Localised Prostate Cancer. A Systematic Review.
Ratti MM; Gandaglia G; Alleva E; Leardini L; Sisca ES; Derevianko A; Furnari F; Mazzoleni Ferracini S; Beyer K; Moss C; Pellegrino F; Sorce G; Barletta F; Scuderi S; Omar MI; MacLennan S; Williamson PR; Zong J; MacLennan SJ; Mottet N; Cornford P; Aiyegbusi OL; Van Hemelrijck M; N'Dow J; Briganti A;
Eur Urol Oncol; 2022 Apr; 5(2):153-163. PubMed ID: 34785188
[TBL] [Abstract][Full Text] [Related]
10. Translation and validation of European organization for research and treatment of cancer quality of life Questionnaire -C30 into Moroccan version for cancer patients in Morocco.
Nejjari C; El Fakir S; Bendahhou K; El Rhazi K; Abda N; Zidouh A; Benider A; Errihani H; Bekkali R
BMC Res Notes; 2014 Apr; 7():228. PubMed ID: 24721384
[TBL] [Abstract][Full Text] [Related]
11. Reliability, validity and responsiveness of the Mandarin (Simplified) Chinese version of the EORTC QLQ-OH45 among cancer patients.
Liu J; Gao J; Wu CX; Bai DX; Li X; Guo XX; Yu JY; Xiao QQ; Bao XR; He LC; Zhong YZ; Chen S
Eur J Cancer Care (Engl); 2019 Mar; 28(2):e12987. PubMed ID: 30614580
[TBL] [Abstract][Full Text] [Related]
12. Psychometric testing of the Norwegian version of the Expanded Prostate Cancer Index Composite 26-item version (EPIC-26).
Fosså SD; Storås AH; Steinsvik EA; Myklebust TA; Eri LM; Loge JH; Dahl AA
Scand J Urol; 2016 Aug; 50(4):280-5. PubMed ID: 27049891
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer.
Wei JT; Dunn RL; Litwin MS; Sandler HM; Sanda MG
Urology; 2000 Dec; 56(6):899-905. PubMed ID: 11113727
[TBL] [Abstract][Full Text] [Related]
14. Reliability and validity of the Amharic version of European Organization for Research and Treatment of cervical Cancer module for the assessment of health related quality of life in women with cervical cancer in Addis Ababa, Ethiopia.
Araya LT; Gebretekle GB; Gebremariam GT; Fenta TG
Health Qual Life Outcomes; 2019 Jan; 17(1):13. PubMed ID: 30642359
[TBL] [Abstract][Full Text] [Related]
15. Translation and validation of Taiwan Chinese version of the self-regulation questionnaire for gynecologic cancer survivors.
Tsai JM; Hsu CY; Tsai LY; Tsay SL
Taiwan J Obstet Gynecol; 2019 Sep; 58(5):614-620. PubMed ID: 31542081
[TBL] [Abstract][Full Text] [Related]
16. Questionnaire to assess quality of life in patients with breast cancer - Validation of the Chinese version of the EORTC QLQ-BR 53.
Zhang Z; Zhang X; Wei L; Lin Y; Wu D; Xie S; Yue L; Tian J; Zhang Y; Song Q; Woo SM; Miller AR; Luo L; Zhang L
Breast; 2017 Apr; 32():87-92. PubMed ID: 28068605
[TBL] [Abstract][Full Text] [Related]
17. Psychometric Validation of the Malaysian Chinese Version of the EORTC QLQ-C30 in Colorectal Cancer Patients.
Magaji BA; Moy FM; Roslani AC; Law CW; Sagap I
Asian Pac J Cancer Prev; 2015; 16(18):8107-12. PubMed ID: 26745046
[TBL] [Abstract][Full Text] [Related]
18. Simplified Chinese Version of the Spinal Instability Neoplastic Score in Evaluating Patients with Metastatic Spinal Tumor: A Cross-Cultural Adaptation and Validation.
Chen J; Wu C; Hong H; Wang X; Zhang J; Xue P; Jiang J; Wang D; Cui Z
Orthop Surg; 2022 Aug; 14(8):1630-1637. PubMed ID: 35715948
[TBL] [Abstract][Full Text] [Related]
19. Translation, cultural adaptation and validation of the Chinese Multimorbidity Treatment Burden Questionnaire(C-MTBQ): a study of older hospital patients.
Dou L; Huang J; Duncan P; Guo L
Health Qual Life Outcomes; 2020 Jun; 18(1):194. PubMed ID: 32571343
[TBL] [Abstract][Full Text] [Related]
20. Reliability and validity of the Chinese version of the autoimmune bullous disease quality of life (ABQOL) questionnaire.
Yang B; Chen G; Yang Q; Yan X; Zhang Z; Murrell DF; Zhang F
Health Qual Life Outcomes; 2017 Feb; 15(1):31. PubMed ID: 28153023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
